Cystine

Cystine

SCHEMBL441236

NC(CCC(=O)O)C(=O)O.NC(CSSCC(N)C(=O)O)C(=O)O

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM8 O00222 2/20 0.75
GRM6 O15303 2/20 0.75
GRM7 Q14831 2/20 0.75
GRM4 Q14833 2/20 0.75
GRIN2D O15399 1/20 0.75
GRIN3B O60391 1/20 0.75
GSR P00390 1/20 0.75
CYP1A2 P05177 1/20 0.75
GRIK1 P39086 1/20 0.75
GRM5 P41594 1/20 0.75
GRIA1 P42261 1/20 0.75
GRIA2 P42262 1/20 0.75
GRIA3 P42263 1/20 0.75
SLC1A3 P43003 1/20 0.75
SLC1A2 P43004 1/20 0.75
SLC1A1 P43005 1/20 0.75
GRIA4 P48058 1/20 0.75
GRIN1 Q05586 1/20 0.75
GRIN2A Q12879 1/20 0.75
GRIK2 Q13002 1/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cystine SCHEMBL5595794 1.00 GRM8 (0.75) GRM8GRM6GRM7GRM4GRIN2D
Cystine SCHEMBL441237 1.00 GRM8 (0.75) GRM8GRM6GRM7GRM4GRIN2D
Cystine SCHEMBL20551359 0.94 GRM8 (0.67) GRM8GRM6GRM7GRM4GRIN2D
Cystine SCHEMBL4890271 0.89 GRM8 (0.56) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL26698369 0.87 GRM8 (0.90) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL3661546 0.87 GRM8 (0.90) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL19900160 0.87 GRM8 (0.90) GRM8GRM6GRM7GRM4GRIN2D
Glutamic Acid SCHEMBL26621747 0.87 GRM8 (0.90) GRM8GRM6GRM7GRM4GRIN2D
Glutamic Acid SCHEMBL2683411 0.87 GRM8 (0.90) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL1330484 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113272421-A Method for generating tumor infiltrating lymphocytes and use thereof in immunotherapy 艾欧凡斯生物治疗公司 2021-08-17 CN claimed
US-20180371643-A1 Method of Identification of Combinatorial Enzymatic Reaction Targets in Glioblastoma Specific Metabolic Network COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2018-12-27 US claimed
WO-2017094025-A1 METHOD OF IDENTIFICATION OF COMBINATORIAL ENZYMATIC REACTION TARGETS IN GLIOBLASTOMA SPECIFIC METABOLIC NETWORK COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2017-06-08 WO claimed
CN-101019530-A Azacycle containing pesticide microemulsion and its prepn ZHOU BENXIN (CN) 2007-08-22 CN claimed
US-20250282720-A1 ALKYLSULFENYL THIOCARBONATES: PRECURSORS TO HYDROPERSULFIDES POTENTLY ATTENUATE OXIDATIVE STRESS THE JOHNS HOPKINS UNIVERSITY 2025-09-11 US disclosed
CN-118932033-A High-sensitivity drug screening platform based on piggyBac transposition system and application thereof 中国药科大学 2024-11-12 CN disclosed
CN-118453649-A Application of iron-dead neutrophil in preparation of antitumor drugs 苏州大学 2024-08-09 CN disclosed
CN-114948943-B New application of large calyx variant A 湖北医药学院 2024-03-08 CN disclosed
CN-115089723-B Glutathione and hydrogen peroxide sensitive manganese-based nanoparticle as well as preparation method and application thereof 中山大学 2024-02-23 CN disclosed
CN-110707221-B Application of amino acid ionic liquid in preparation of perovskite layer in perovskite photoelectric device 北京大学深圳研究生院 2023-09-01 CN disclosed
WO-2022232622-A1 ALKYLSULFENYL THIOCARBONATES: PRECURSORS TO HYDROPERSULFIDES POTENTLY ATTENUATE OXIDATIVE STRESS THE JOHNS HOPKINS UNIVERSITY (US) 2022-11-03 WO disclosed
CN-115089723-A Glutathione and hydrogen peroxide sensitive manganese-based nanoparticles and preparation method and application thereof 中山大学 2022-09-23 CN disclosed
CN-107735094-A New use of inhibitors of cystine-glutamate transporter 中国医药大学 2018-02-23 CN disclosed
WO-2017094025-A1 METHOD OF IDENTIFICATION OF COMBINATORIAL ENZYMATIC REACTION TARGETS IN GLIOBLASTOMA SPECIFIC METABOLIC NETWORK COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2017-06-08 WO disclosed
US-20130296185-A1 TAPE STRIPPING METHODS FOR ANALYSIS OF SKIN DISEASE AND PATHOLOGICAL SKIN STATE DERMTECH INTERNATIONAL (US) 2013-11-07 US disclosed
US-20120065086-A1 Tape stripping methods for analysis of skin desease and pathological skin state DERMTECH, LLC 2012-03-15 US disclosed
US-20120046232-A1 COMPOSITIONS AND METHODS FOR REDUCING RELAPSE OF ADDICTIVE BEHAVIOR MEDICAL UNIVERSITY OF SOUTH CAROLINA 2012-02-23 US disclosed
CN-101019530-A Azacycle containing pesticide microemulsion and its prepn ZHOU BENXIN (CN) 2007-08-22 CN disclosed
US-RE39734-E1 Selenium source, a glutathione precursor of glutamic acid, cystine and glycine; increasing the content of glutathione in body tissue above that of a pretreatment level, enhancing immune activity CRUM ALBERT 2007-07-17 US disclosed
US-4767748-A Substituted oligosaccharide antibodies SCHERING CORPORATION (US) 1988-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046232-A1 COMPOSITIONS AND METHODS FOR REDUCING RELAPSE OF ADDICTIVE BEHAVIOR GRM6, GRM5, GRM7 GRM8 17/4885GRM6 1/4885GRM7 3/4885
US-20250282720-A1 ALKYLSULFENYL THIOCARBONATES: PRECURSORS TO HYDROPERSULFIDES POTENTLY ATTENUATE OXIDATIVE STRESS FECH, HAGH, TST GRM8 3316/4885GRM6 2361/4885GRM7 3874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.